Medical news update
- JAMA Cardiology Peer Reviewers in 2024
We sincerely thank the 715 peer reviewers who completed manuscript reviews for JAMA Cardiology in 2024.
- Importance of Age and Sex in Carotid Artery Plaque Detection and Cardiovascular Disease Risk
This cohort study among participants in the Multi-Ethnic Study of Atherosclerosis (MESA) describes carotid artery plaque prevalence by age, sex, race, and ethnicity and investigates whether the […]
- Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy
Coronary artery calcium (CAC) testing is extremely appealing as a primary prevention strategy to personalize risk assessment and individualize the intensity of preventive therapy. This is because the […]
- Food Insecurity and Incident Cardiovascular Disease Among Black and White US Individuals, 2000-2020
This cohort study among adult participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study investigates whether food insecurity is associated with incident cardiovascular […]
- JAMA Cardiology
Mission Statement: JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, […]
- Trajectory of Cardiovascular Health Across Childhood and Adolescence
This cohort study evaluates cardiovascular health among children and adolescents and its association with sociodemographic variables.
- Outcomes of Asymptomatic Transthyretin Cardiac Amyloid Infiltration
This cohort study characterizes the clinical phenotype and natural history of asymptomatic patients with transthyretin cardiac amyloid infiltration.
- Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis
This study investigates sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance and evaluates its prognostic value in women and men with aortic stenosis.
- Metformin for covid-19: systematic review and meta-analysis of randomised controlled trials
- Metformin for covid-19: systematic review and meta-analysis of randomised controlled trials
- Ending nuclear weapons, before they end us
- Ending nuclear weapons, before they end us
- Understanding research on artificial intelligence in healthcare
- Understanding research on artificial intelligence in healthcare
- Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study
- Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study
- Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study
- Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study
- Posts will be published when available. Sorry for inconvenience
- ESH MASTERplan for Hypertension Management in CKD – webinars
Did you miss the webinar “ESH MASTERplan for Hypertension Management in CKD”? The recording is now available HERE
- Summer School 2025
Date: 14-19 September 2025 Venue: Särö (Gothenburg), Sweden
- NEW ESH 2024 webinars
Webinar 1: Key Points of the Hypertension Guidelines - The ESH MASTERplan for hypertension Webinar 2: Managing Hypertensive Patients in Clinical Practice – Update on the management of […]
- ESH 2025
Milan - May 23-26 MICO Congresso Center FEBRUARY 21, 2025 - OPENING SUBMISSION LATE-BREAKERS ABSTRACTS
- ESH Webinars 2024
PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies PART 2: Hypertension treatment challenges and options in comorbidities
- ESH 2024
BERLIN MAY 31 - JUNE 3, 2024 www.eshannualmeetings.eu Abstracts are available in Journal of Hypertension
- NEW EUROPEAN GUIDELINES
The final version of the full guidelines is now available on the Journal of Hypertension website.
- Webinar series
HOT TOPICS IN HYPERTENSION MANAGEMENT - AUTUMN 2020 (Part 2) - NOW AVAILABLE.
- Advanced Practice Nurse Intervention Versus Usual Care for Hypertension Control: A Pilot Open‐Label Randomized Controlled Trial
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Trends and Disparities in Heart Failure Mortality Among Hypertensive Older Adults in the United States: A 22‐Year Retrospective Study
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Relationship Between the Drop Rate of Standing Blood Pressure and Major Adverse Cardiovascular Events
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- LC‐MS/MS‐Based Assay for Steroid Profiling in Peripheral and Adrenal Venous Samples for the Subtyping of Primary Aldosteronism
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Gender and Age Differentials in Prevalence and Pattern of Nine Chronic Diseases Among Older Adults in India: An Analysis Based on Longitudinal Ageing Study in India
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Causal Effects Between Blood Pressure Variability and Alzheimer's Disease: A Two‐Sample Mendelian Randomization Study
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Photoplethysmography‐Derived Arterial Stiffness Index Delivered Greater Cardiovascular Prevention Value to Non‐Elderly: A Retrospective Cohort Study Based on UK Biobank
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Uric Acid Serves as a Risk Factor or Marker for Developing Hypertension According to Both Conventional and Novel Definitions: An Association or Causation!
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.
- Multiple system biology approaches reveals the role of the hsa-miR-21 in increasing risk of neurological disorders in patients suffering from hypertension
Journal of Human Hypertension, Published online: 20 May 2025; doi:10.1038/s41371-025-01027-3Multiple system biology approaches reveals the role of the hsa-miR-21 in increasing risk of neurological […]
- Association of ambient temperature and blood pressure in the Jackson Heart Study
Journal of Human Hypertension, Published online: 15 May 2025; doi:10.1038/s41371-025-01026-4Association of ambient temperature and blood pressure in the Jackson Heart Study
- The mislaid clue to APOL1 kidney disease prevention in blacks
Journal of Human Hypertension, Published online: 07 May 2025; doi:10.1038/s41371-025-01024-6The mislaid clue to APOL1 kidney disease prevention in blacks
- Assessment of clinical pharmacist outreach and medication titration in remote patient monitoring program for hypertension
Journal of Human Hypertension, Published online: 06 May 2025; doi:10.1038/s41371-025-01025-5Assessment of clinical pharmacist outreach and medication titration in remote patient monitoring program […]
- The relationship between physical activity, orthostatic blood pressure reactions and subclinical atherosclerosis: the Swedish CArdioPulmonary bioImage Study (SCAPIS)
Journal of Human Hypertension, Published online: 05 May 2025; doi:10.1038/s41371-025-01022-8The relationship between physical activity, orthostatic blood pressure reactions and subclinical […]
- Influence of various legwear during arterial stiffness measurement
Journal of Human Hypertension, Published online: 04 May 2025; doi:10.1038/s41371-025-01023-7Influence of various legwear during arterial stiffness measurement
- Blood pressure response to mineralocorticoid receptor antagonists or aldosterone synthase inhibitors according to baseline renin levels
Journal of Human Hypertension, Published online: 03 May 2025; doi:10.1038/s41371-025-01021-9Blood pressure response to mineralocorticoid receptor antagonists or aldosterone synthase inhibitors […]
- ABSTRACTS FROM THE 6th WORLD HYPERTENSION CONGRESS CHENNAI, INDIA
Journal of Human Hypertension, Published online: 02 May 2025; doi:10.1038/s41371-025-01016-6ABSTRACTS FROM THE 6th WORLD HYPERTENSION CONGRESS CHENNAI, INDIA
- New Life for a Failed Drug Class
An oral CETP inhibitor — both alone and combined with ezetimibe — significantly reduced LDL-C in high-risk patients already on cholesterol-lowering therapies.
- Support for Moderate-Intensity Statin plus Ezetimibe in Older Patients
Compared with high-intensity statins, this alternate regimen lowered LDL-C similarly, with significantly fewer muscle symptoms, in patients 70 and older.
- Can Electronic Provider Notification Improve Outcomes in Severe Aortic Stenosis?
A randomized trial provides a strong signal of benefit.
- Do Patients with Histories of Takotsubo Syndrome Have Increased Long-Term Morbidity?
Yes, and not all of the morbidity is cardiovascular.
- Can a “Ligand Trap” Finally Bend the Mortality Curve in Advanced PAH?
When added to maximal therapy, sotatercept significantly reduced risk for death, transplantation, or hospitalization in a high-risk population.
- Assessment of Chronic Aortic Insufficiency
Echocardiography criteria and MRI findings correlated well for hemodynamically significant AI.
- A Meta-Analysis of IV Iron Repletion in Heart Failure with Reduced Ejection Fraction
Iron repletion lowered risk for a composite endpoint of HF hospitalization or cardiovascular death, without safety concerns.
- Does Evolocumab Decrease CV Events in At-Risk Patients with Autoimmune or Inflammatory Disease?
Yes, dramatically so, according to a subgroup analysis of clinical trial data.